Christopher Allen Rock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christopher Allen Rock has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Abba M. Krieger
Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, 19104, USA
2 shared publications- Giovanni Ferrari
Department of Surgery, Columbia University, New York, USA
2 shared publications Samuel Keeney
The Pediatric Heart Valve Center, Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA
2 shared publicationsAndrey Zakharchenko
Pediatric Heart Valve Center, Division of Cardiology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104
1 shared publication- Andrey Zakharchenko
The Pediatric Heart Valve Center, Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA
1 shared publication Anne L. Philip
Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA
1 shared publication
Latest Publications
- Open Access
- 24 July 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-16
Voxel-scale diffusion tensor phenomapping of the healthy and pressure-overloaded human heart
- 24 July 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-16
Open AccessVoxel-scale diffusion tensor phenomapping of the healthy and pressure-overloaded human heart
- Open Access
- 6 September 2022
- Published by Elsevier in Biomaterials
- Vol. 289, 121782
Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment
- 6 September 2022
- Published by Elsevier in Biomaterials
- Vol. 289, 121782
Open AccessInhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment
- Open Access
- 7 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (6)
Poly-2-methyl-2-oxazoline–modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration
Significance: Heart valve disease affects millions, and since there is no effective medical therapy, surgical repair when possible—or more commonly, replacement—are the only treatments available. Bioprosthetic heart valves (BHV), the most frequently used valve replacements, are composed of heterograft tissue, typically fixed in glutaraldehyde, and prepared for human use either as surgically implantable devices or for transcatheter delivery. Protein-glycation limits the durability of BHV, contributing to device failure, often requiring reoperation after only a decade or less of functionality. This problem is addressed by modifying BHV leaflets with poly-2-methyl-2-oxazoline, effectively mitigating glycation and serum protein infiltration and enhancing biocompatibility.
- 7 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (6)
Open AccessPoly-2-methyl-2-oxazoline–modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration
Significance: Heart valve disease affects millions, and since there is no effective medical therapy, surgical repair when possible—or more commonly, replacement—are the only treatments available. Bioprosthetic heart valves (BHV), the most frequently used valve replacements, are composed of heterograft tissue, typically fixed in glutaraldehyde, and prepared for human use either as surgically implantable devices or for transcatheter delivery. Protein-glycation limits the durability of BHV, contributing to device failure, often requiring reoperation after only a decade or less of functionality. This problem is addressed by modifying BHV leaflets with poly-2-methyl-2-oxazoline, effectively mitigating glycation and serum protein infiltration and enhancing biocompatibility.
- 16 July 2021
- Published by Drexel University Libraries
The Role of Fiber Bundle and Membrane Subunits in Aortic Valve Function
Heart valves are complex arrangements of collagen fibers and membranes that oppose retrograde blood flow during contraction of the cardiac chambers. Through its amazing lifetime, the normal healthy valve cycles over 3 billion times. However, disease (such as stenosis/calcification or mechanical wear) can cause the valve to malfunction, permitting backflow or failing to properly open. When a valve cannot be salvaged, treatment can require replacement of the valve to improve hydrodynamic behavior. Replacements are either a mechanical valve or, more commonly, a bioprosthetic valve made of either porcine valves or bovine pericardium. Although bioprosthetic implants are highly successful short-term, their long term durability is still limited. Alternatively, the patient can use a synthetic mechanical valve which will likely necessitate blood thinners for the remainder of his/her life. Thus, there is need for replacement valves that possess both superior durability and hemodynamic function. Current bioprosthetic and mechanical designs do not fully consider the underlying native fiber structure of the aortic valve, nor their fiber-scale biomechanical properties. In the past, the challenge of testing at the fiber bundle length scale precluded experimentation. Thus, there was little previously known regarding how the fiber bundles and membrane structures are arranged as well as their exact role in aortic valve function. The overall objective of this work was to perform experimental and analytical analyses of the individual collagen fiber and membrane "mesostructures" of the aortic valve. We developed a novel experimental/analytical system to investigate these structures in detail. Using this system, we were able to perform a detailed characterization of the substructures' morphology and the first quantification of their biomechanical properties. This work offers new insights in structure-function adaptations of the native aortic valve at the tissue level. In addition to the application of a more effective replacement valve design, the results of this thesis can be used in the generation of more precise mathematical models of aortic valve loading behavior.
- 16 July 2021
- Published by Drexel University Libraries
The Role of Fiber Bundle and Membrane Subunits in Aortic Valve Function
Heart valves are complex arrangements of collagen fibers and membranes that oppose retrograde blood flow during contraction of the cardiac chambers. Through its amazing lifetime, the normal healthy valve cycles over 3 billion times. However, disease (such as stenosis/calcification or mechanical wear) can cause the valve to malfunction, permitting backflow or failing to properly open. When a valve cannot be salvaged, treatment can require replacement of the valve to improve hydrodynamic behavior. Replacements are either a mechanical valve or, more commonly, a bioprosthetic valve made of either porcine valves or bovine pericardium. Although bioprosthetic implants are highly successful short-term, their long term durability is still limited. Alternatively, the patient can use a synthetic mechanical valve which will likely necessitate blood thinners for the remainder of his/her life. Thus, there is need for replacement valves that possess both superior durability and hemodynamic function. Current bioprosthetic and mechanical designs do not fully consider the underlying native fiber structure of the aortic valve, nor their fiber-scale biomechanical properties. In the past, the challenge of testing at the fiber bundle length scale precluded experimentation. Thus, there was little previously known regarding how the fiber bundles and membrane structures are arranged as well as their exact role in aortic valve function. The overall objective of this work was to perform experimental and analytical analyses of the individual collagen fiber and membrane "mesostructures" of the aortic valve. We developed a novel experimental/analytical system to investigate these structures in detail. Using this system, we were able to perform a detailed characterization of the substructures' morphology and the first quantification of their biomechanical properties. This work offers new insights in structure-function adaptations of the native aortic valve at the tissue level. In addition to the application of a more effective replacement valve design, the results of this thesis can be used in the generation of more precise mathematical models of aortic valve loading behavior.